Blood Donation<br>Component Preparation and Storage<br>Blood Components<br>Red Blood Cell Antigens and<br>Human Blood Groups<br>Pretransfusion Compatibility Testing<br>Serologic Investigation of Unexpected Antibodies<br>Leukoreduced Products: Prevention of Leukocyte-Related Transfusion-Associated Adverse Effects<br>Preparation of Blood Components to Reduce Cytomegalovirus and Other Infectious Risks<br>Irradiated Products<br>Washed and/or Volume-Reduced Blood Components<br>Technical Considerations/Mechanical Devices<br>Red Blood Cell Transfusions in the Neonate, Infant, Child, and Adolescent<br>Transfusion of the Pediatric Surgery, Trauma, and Intensive Care Unit Patient<br>Pediatric Transfusion in Developing Countries<br>Exchange Transfusion in the Infant<br>Granulocyte Transfusions in the Neonate and Child<br>Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass<br>Hemolytic Disease of the Newborn<br>Hemoglobinopathies<br>The Bleeding Child: Congenital and Acquired Disorders<br>Transfusion of the Patient with Autoimmune Hemolysis<br>Platelet Transfusions in the Infant and Child<br>Bone Marrow–Derived Stem Cells<br>Peripheral Blood Stem Cells<br>Umbilical Cord Blood Stem Cells<br>Transfusion Reactions<br>Noninfectious Complications of Pediatric Transfusion<br>Infectious Complications<br>Therapeutic Apheresis<br>Therapeutic Cytapheresis<br>Therapeutic Plasma Exchange: Rationales and Indications<br>Appendix Transfusion Formulas